Clinical Topics & News
Latest News
CDC: Masking no longer required in health care settings
The new guidance applies wherever health care is delivered, including nursing homes and home health.
News
Drug combo holds promise of better AML outcomes
Study suggests that the venetoclax-gilteritinib drug combination “potentially improves response frequency and depth.”
News
Cost paramount when choosing metastatic breast cancer treatment
“Our analysis provides quantifiable evidence to help providers choose lower priced, but equally effective sequences of drugs.”
News
Meet our newest genetically engineered frenemy, herpes
Plus: Cooking and cleaning your way to air pollution, dying to become a tree, and thawing out “COVID-frozen” goals.
News
Despite benefits, extended-interval pembro uptake remains low
It’s possible that low uptake could stem from clinicians’ doubts about switching to an extended-interval dose, given that the FDA’s approval was...
News
Genetic tests create treatment opportunities and confusion for breast cancer patients
Patients are sometimes left paying out-of-pocket for exams that are not yet the standard of care, and even the most up-to-date oncologists may be...
Latest News
Experts sound alarm on ruling threatening preventive cancer care
Experts are concerned that the ruling will force some individuals to pay out of pocket for preventive cancer screenings.
Clinical Topics & News
VA Launches Virtual Tumor Board
Conference Coverage
Time to cancer diagnoses in U.S. averages 5 months
Diagnosis time varied significantly across tumor types, as well as within the same tumor type.
News
BRAF/MEK combo shows long-term efficacy in melanoma
Despite positive results, immunotherapy likely remains the best choice for first-line treatment of BRAFV600 mutated advanced melanoma.
